Metabolic brain diseaseHumansDiabetes MellitusType 2MetforminMyasthenia Gravis
Interconnection between myasthenia gravis and type 2 diabetes: emerging role of metformin in modulating PI3K/AKT/mTOR/AMPK axis.
Ahmed Salem Al-Dhahi, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Ali K Albuhadily, Aya M Mustafa, Alaa Ismail, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
Published: 202510.1007/s11011-025-01745-0
Abstract
Myasthenia gravis (MG) represents the commonest autoimmune disorder affecting the neuromuscular junction (NMJ). The pathophysiology of MG is mainly linked to the formation of IgG autoantibodies directed against acetylcholine receptors (AChRs) in the…
Preview only. Read the full abstract at the source